These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The pill and thromboembolism. 1. Thrombogenesis and additional risk factors. A review of the literature]. Herzog C; Mall-Haefeli M Ther Ggw; 1979 Oct; 118(10):1550-74. PubMed ID: 386549 [No Abstract] [Full Text] [Related]
4. [Oral contraceptives: pharmacotherapy of normal women (author's transl)]. Bühler FR Schweiz Rundsch Med Prax; 1976 Jan; 65(1):3-5. PubMed ID: 1250821 [TBL] [Abstract][Full Text] [Related]
5. [Problem of oral surgical interventions during pregnancy, menstruation and under the intake of hormonal contraceptives]. Stech E Stomatol DDR; 1979 Apr; 29(4):298-303. PubMed ID: 313090 [TBL] [Abstract][Full Text] [Related]
6. [Hormonal contraception--side effects and surgical aspects (author's transl)]. Göretzlehner G; Carol W; Köhler G Zentralbl Chir; 1980; 105(24):1601-16. PubMed ID: 7015744 [TBL] [Abstract][Full Text] [Related]
7. [Oral contraceptives and thromboembolism (author's transl)]. Sato K; Ogino M; Nakabayashi M; Sakamoto S Kokyu To Junkan; 1978 Mar; 26(3):212-20. PubMed ID: 349637 [No Abstract] [Full Text] [Related]
8. [Oral contraceptives: cardiovascular complications and additional risk factors (author's transl)]. Herzog C Schweiz Rundsch Med Prax; 1979 Oct; 68(41):1321-9. PubMed ID: 394143 [No Abstract] [Full Text] [Related]
9. [Thromboembolic attacks in the central nervous system and P-pills]. Lidegaard O Ugeskr Laeger; 1982 Sep; 144(38):2769-72. PubMed ID: 7157502 [TBL] [Abstract][Full Text] [Related]
10. [Hormonal contraceptive therapy and thromboembolic disease]. Narvaiza MJ; Hernández M; Arrizabalaga B; Solana JM; Pérez Val JA; Rocha E Rev Med Univ Navarra; 1980 Dec; 24(4):49-53. PubMed ID: 7038816 [TBL] [Abstract][Full Text] [Related]
11. [Contraception in risk patients. Discussion]. Detering K; Hartmann E Med Welt; 1980 Dec; 31(49):1805-6. PubMed ID: 7207122 [No Abstract] [Full Text] [Related]
12. [Hormonal contraceptive agents as a risk factor in the development of acute thromboembolic diseases]. Lambrekht R; Vageman V; Vinkelman B; Geĭnrikh P Khirurgiia (Mosk); 1986 Dec; (12):90-3. PubMed ID: 3821001 [TBL] [Abstract][Full Text] [Related]
13. [Behavior of heparinocytes and of fibrinolytic degradation products after discontinuation of hormonal contraceptives]. Frick G; Göretzlehner G; Frick U Zentralbl Gynakol; 1976; 98(15):908-13. PubMed ID: 969999 [TBL] [Abstract][Full Text] [Related]
14. [In consideration of few mentioned aspects by application of hormonal contraceptives (author's transl)]. Gitsch E Ther Umsch; 1976 Apr; 33(4):218-21. PubMed ID: 1006576 [No Abstract] [Full Text] [Related]